Renaissance BioScience Secures Landmark Patent for Revolutionary RNA Production and Delivery Technology


Vancouver, Canada, Oct. 24, 2023 (GLOBE NEWSWIRE) — Renaissance BioScience Corp (, a leader in bioengineering for the global agriculture, animal health, human medicine, and food sector, is pleased to announce its recent patent award from the China patent office. This patent grant, representing the first for its innovative yeast-based platform technology for the production and delivery of RNA bioactive molecules, enhances Renaissance’s robust IP portfolio, which includes 50 previous patent awards and 11 pending applications across major global markets. Given China’s status as the world’s top pesticide consumer and leading biopesticide producer, this patent award covering the enormous Chinese market is particularly significant.

For the full release, click here.

This state-of-the-art yeast platform technology is poised to transform the global agriculture industry with its precise, targeted approach to pest control. Moreover, its implications reach far beyond, with numerous promising applications in animal health and human medicine.


Dr. John Husnik, Renaissance’s CSO, shared his enthusiasm: “This groundbreaking patent in China solidifies our position as innovators in the global RNA technology landscape. As our patent portfolio expands, we anticipate tapping into a plethora of opportunities, not just within China but on an international scale.”

Key advantages of Renaissance’s yeast-based RNA technology include:

Stability: Yeast’s robust nature ensures RNA molecule protection in varied environments.

Manufacturing: Economical, scalable, and quality-driven yeast production means cost-efficient RNA bioactive molecule manufacturing.

Adaptability: The platform’s versatility supports multiple gene targeting and compound integration, amplifying its applicability.

Safety: Utilizing inactivated food-grade baker’s yeast ensures safety, paving the way for smoother regulatory approvals.
Renaissance’s biopesticides harness RNA interference (RNAi) to selectively inhibit proteins crucial to a target pests’ development. This focused approach strives to maintain the specificity of RNAi’s impact on its intended target, safeguarding the well-being of other living organisms. Additionally, its biodegradable nature ensures no effect on the environment..

About Renaissance BioScience Corp.
Renaissance BioScience, headquartered in Vancouver, is at the forefront of microbial bioengineering innovation. Their groundbreaking technologies are shaping the future across various industries, from agriculture, food and beverage to health and energy. Dive deeper at

For more information:

Steve Campbell
Campbell & Company Strategies Inc.
01 604 888-5267
[email protected]

Reesha Parmar
[email protected]

Maurice Boucher
[email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.